Technologieangebote

Tumorantigene für diagnostische und therapeutischen Zwecke

This technology offer contains three patent applications of Saarland University that provide methods for the diagnosis of tumours in an early stage, especially in cases of lung and brain cancer and COPD (chronic obstructive pulmonary disease).

The technologies are using a single diagnostic marker or a panel of biomarkers to diagnose the diseases in an early stage which can imply an enormous improvement on the efficacy of subsequent therapies.

Weitere Informationen: PDF

Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Tel.: +49 (0)681/302-71302

Ansprechpartner
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Hauke Studier, Dr. Susanne Heiligenstein

Kommentare (0)

Schreiben Sie einen Kommentar